Keybanc Maintains Overweight on ICU Medical, Raises Price Target to $198
Portfolio Pulse from Benzinga Newsdesk
Keybanc analyst Brett Fishbin maintains an Overweight rating on ICU Medical (NASDAQ:ICUI) and raises the price target from $147 to $198.
October 15, 2024 | 11:52 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Keybanc analyst Brett Fishbin has increased the price target for ICU Medical from $147 to $198 while maintaining an Overweight rating. This suggests a positive outlook for the company's stock.
The increase in price target from $147 to $198 by Keybanc, along with maintaining an Overweight rating, indicates a strong positive sentiment from the analyst. This is likely to boost investor confidence and could lead to a short-term increase in ICUI's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100